Issue 1/2022
Content (29 Articles)
Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?
Karolina Kaźmierczak-Siedlecka, Agnieszka Daca, Giandomenico Roviello, Martina Catalano, Karol Połom
Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women
Joo Hyun Lim, Cheol Min Shin, Kyungdo Han, Juhwan Yoo, Eun Hyo Jin, Yoon Jin Choi, Dong Ho Lee
Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit
Marianne C. Kalff, Anna D. Wagner, Rob H. A. Verhoeven, Valery E. P. P. Lemmens, Hanneke W. M. van Laarhoven, Suzanne S. Gisbertz, Mark I. van Berge Henegouwen
Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study
Young Min Kim, Jie-Hyun Kim, Jong Suk Park, Su Jung Baik, Jaeyoung Chun, Young Hoon Youn, Hyojin Park
Correction to: Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study
Young Min Kim, Jie-Hyun Kim, Jong Suk Park, Su Jung Baik, Jaeyoung Chun, Young Hoon Youn, Hyojin Park
Hypoxia associated lncRNA HYPAL promotes proliferation of gastric cancer as ceRNA by sponging miR-431-5p to upregulate CDK14
Hai-yan Piao, Yang Liu, Ye Kang, Yue Wang, Xiang-yu Meng, Dong Yang, Jun Zhang
CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6
Peng Xu, XiaoLan Xu, Xiao Wu, LiXiang Zhang, Lei Meng, ZhangMing Chen, WenXiu Han, Jie Yao, AMan Xu
Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma
Menghua Zhang, Itsuki Sugita, Daisuke Komura, Hiroto Katoh, Shu Shimada, Johji Inazawa, Shinji Tanaka, Shumpei Ishikawa
Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model
Cong-hui Zhu, Shuang-qing Peng, Li-li Cui, Wanying Cao, Li-shi Zhang, Zeng-ming Zhao, Li Jia, Ting-fen Zhang, Jia-bin Guo, Chengfang Pang
Insulin and the insulin receptor collaborate to promote human gastric cancer
Marina Saisana, S. Michael Griffin, Felicity E. B. May
Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells
Joana Figueiredo, Rui M. Ferreira, Han Xu, Margarida Gonçalves, André Barros-Carvalho, Janine Cravo, André F. Maia, Patrícia Carneiro, Céu Figueiredo, Michael L. Smith, Dimitrije Stamenović, Eurico Morais-de-Sá, Raquel Seruca
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE
Kenichiro Furukawa, Keiichi Hatakeyama, Masanori Terashima, Takeshi Nagashima, Kenichi Urakami, Keiichi Ohshima, Akifumi Notsu, Takashi Sugino, Taisuke Yagi, Keiichi Fujiya, Satoshi Kamiya, Makoto Hikage, Yutaka Tanizawa, Etsuro Bando, Yae Kanai, Yasuto Akiyama, Ken Yamaguchi
Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer
Seong-Woo Bae, Felix Berlth, Kyoung-Yun Jeong, Ji-Hyeon Park, Jong-Ho Choi, Shin-Hoo Park, Yun-Suhk Suh, Seong-Ho Kong, Do-Joong Park, Hyuk-Joon Lee, Charles Lee, Jong-Il Kim, Hyewon Youn, Hongyoon Choi, Gi Jeong Cheon, Keon Wook Kang, Han-Kwang Yang
Brain metastases in gastroesophageal cancers—an underestimated complication
Marius Brunner, Dominik Soll, Kathrin Adler, André Sasse, Ute König, Ardian Mekolli, Kristina Lowes, Johanna Reinecke, Volker Ellenrieder, Alexander König
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study
Hyung-Don Kim, Jong Seok Lee, Jeong Hwan Yook, Min-Hee Ryu, Young-Kyu Park, Jin Young Kim, Young-Woo Kim, Sang Cheul Oh, Jong Gwang Kim, Jae-Ho Cheong, Oh Jeong, Sung Hoon Noh, Yoon-Koo Kang
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601
Masaaki Iwatsuki, Hiroyuki Orita, Kazuma Kobayashi, Shigekazu Hidaka, Takaaki Arigami, Tetsuya Kusumoto, Hironaga Satake, Eiji Oki, Satoshi Tsutsumi, Kazutoshi Tobimatsu, Mototsugu Shimokawa, Hiroshi Saeki, Akitaka Makiyama, Hideo Baba, Masaki Mori
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07
Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi, Takeshi Sano, Wataru Ichikawa, Sang-Woong Lee, Kazushige Shibahara, Toshio Shikano, Masato Kataoka, Atsushi Ishiguro, Hitoshi Ojima, Yoshinori Sakai, Nobuyuki Musha, Tsunenobu Takase, Taisei Kimura, Masahiro Takeuchi, Masashi Fujii
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
Charles S. Fuchs, Mustafa Özgüroğlu, Yung-Jue Bang, Maria Di Bartolomeo, Mario Mandala, Min-Hee Ryu, Lorenzo Fornaro, Tomasz Olesinski, Christian Caglevic, Hyun C. Chung, Kei Muro, Eric Van Cutsem, Anneli Elme, Peter Thuss-Patience, Ian Chau, Atsushi Ohtsu, Pooja Bhagia, Anran Wang, Chie-Schin Shih, Kohei Shitara
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
Yoon-Koo Kang, Satoshi Morita, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Hiroki Sameshima, Li-Tzong Chen, Narikazu Boku
New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor
Tomo Ishida, Tsuyoshi Takahashi, Toshirou Nishida, Hiromitsu Ohnishi, Takahiro Tsuboyama, Shinsuke Sato, Yujiro Nakahara, Yasuhiro Miyazaki, Atsushi Takeno, Yukinori Kurokawa, Takuro Saito, Kotaro Yamashita, Koji Tanaka, Kazuyoshi Yamamoto, Tomoki Makino, Makoto Yamasaki, Masaaki Motoori, Yutaka Kimura, Kiyokazu Nakajima, Hidetoshi Eguchi, Yuichiro Doki
Insertion–deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab
Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Sun Young Lee, Meesun Moon, Yoon-Koo Kang
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)
Yoshikazu Takahashi, Yu Sunakawa, Eisuke Inoue, Ryohei Kawabata, Atsushi Ishiguro, Yosuke Kito, Yusuke Akamaru, Masazumi Takahashi, Hiroshi Yabusaki, Jin Matsuyama, Akitaka Makiyama, Masahiro Tsuda, Takahisa Suzuki, Hisateru Yasui, Ryo Matoba, Hisato Kawakami, Takako Eguchi Nakajima, Kei Muro, Wataru Ichikawa, Masashi Fujii
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study
Kensei Yamaguchi, Narikazu Boku, Kei Muro, Kazuhiro Yoshida, Hideo Baba, Shinji Tanaka, Ayumi Akamatsu, Takeshi Sano
Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study
Kensei Yamaguchi, Narikazu Boku, Kei Muro, Kazuhiro Yoshida, Hideo Baba, Shinji Tanaka, Ayumi Akamatsu, Takeshi Sano
Development of a predictive model for extragastric recurrence after curative resection for early gastric cancer
Jae Seok Bae, Won Chang, Se Hyung Kim, Yunhee Choi, Seong-Ho Kong, Hyuk-Joon Lee, Han-Kwang Yang, Yoonjin Kwak, Hyung-Ho Kim, Joon Koo Han
Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score
Yeongkeun Kwon, Jin-Won Kwon, Jane Ha, Dohyang Kim, Jaehyeong Cho, Soo Min Jeon, Shin-Hoo Park, Jinseub Hwang, Nam Hoon Kim, Sungsoo Park
Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients
Seohee Choi, Jeong Ho Song, Sejin Lee, Minah Cho, Yoo Min Kim, Hyoung-Il Kim, Woo Jin Hyung
Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection?
Yusuke Muneoka, Manabu Ohashi, Naoki Ishizuka, Masaru Hayami, Rie Makuuchi, Satoshi Ida, Koshi Kumagai, Takeshi Sano, Souya Nunobe
Correction to: DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial–mesenchymal transition in gastric cancer
Yu Liang, Chun-Dong Zhang, Cheng Zhang, Dong-Qiu Dai